Sensei Biotherapeutics, Inc. SNSE 深 沪
等待开盘 05-22 09:30:00 美东时间
17.56
-0.020
-0.11%
华盛通- 最 高18.40
- 今 开17.18
- 成交量 1.60万股
- 最 低 17.18
- 昨 收 17.58
- 总市值 2355.04万
- 52周最高 36.76
- 市盈率 静 --
- 换手率 1.19%
- 52周最低 5.60
- 委 比 -98.28%
- 总股本 134.11万
- 历史最高 530.00
- 量 比 0.44
- 振 幅 6.94%
- 历史最低 5.00
- 每 手 1
- 风险率 9.01%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Sensei Biotherapeutics Sets Vote on Series B Conversion
The latest update is out from Sensei Biotherapeutics ( ($SNSE) ). Sensei Biothe...
今天 07:31
Sensei Biotherapeutics Q1 EPS $(131.45) Misses $(0.62) Estimate
Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(131.45) per share which missed the analyst consensus estimate of $(0.62) by 21101.61 percent. This is a 2334.26 percent decrease over losses of $(5.40)
05-15 19:35
Sensei Biotherapeutics Says First Patient Dosed In Study FTH-PIK-101, Phase 1b/2 Trial Of PIKTOR In Patients With HR+/HER2- Advanced Breast Cancer
PIKTOR is an investigational all-oral, multi-node inhibitor targeting escape routes in the PI3K/AKT/mTOR pathway that single-node inhibitors leave openSensei Biotherapeutics, Inc. (NASDAQ:SNSE), a clinical-stage
05-05 19:34
5月医疗保健股多空榜：Sensei及KalVista空头比例居前
随着4月结束，市值20亿美元以下的小型医疗保健股空头头寸显著增加，显示市场对这类高波动性股票的看空情绪升温。 根据最新数据，5月初医疗保健板块空头比例最...
05-05 03:24
Sensei Biotherapeutics Announces Leadership and Board Transitions
Sensei Biotherapeutics ( ($SNSE) ) just unveiled an update. On April 10, 2026, ...
04-17 04:51
Sensei Biotherapeutics to present at Needham Virtual Healthcare Conference
Sensei Biotherapeutics to present at Needham Virtual Healthcare Conference Sensei Biotherapeutics management will present at Needham 25th Annual Virtual Healthcare Conference on April 16, 2026 at 12:45 p.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative ar
04-09 19:34
BRIEF-Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update
BRIEF-Sensei Biotherapeutics Reports Full Year 2025 Financial Results And Provides Corporate Update March 30 (Reuters) - Sensei Biotherapeutics Inc SNSE.O : SENSEI BIOTHERAPEUTICS REPORTS FULL YEAR 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE Source text: ID:nBwjmfmya Further company coverag
03-30 20:01
Sensei Biotherapeutics Q4 EPS $(3.74) Beats $(4.11) Estimate
Sensei Biotherapeutics (NASDAQ:SNSE) reported quarterly losses of $(3.74) per share which beat the analyst consensus estimate of $(4.11) by 9 percent. This is a 39.68 percent increase over losses of $(6.20) per share
03-30 19:50
Sensei Biotherapeutics GAAP EPS of -$16.72
Sensei Biotherapeutics press release (SNSE): FY GAAP EPS of -$16.72. Cash, cash equivalents and marketable securities were $21.2 million as of December 31, 2025 as compared to $41.3 million as of Dece...
03-30 19:37
